Analyst Ratings for Ascendis Pharma (ASND) [Buys]
ASND Rating Summary
ASND Price Target Summary
- Highest: $260.00 (Wells Fargo)
- Lowest: $89.00 (Credit Suisse)
- Average: $169.44
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$169.44 (+19.7%)
* Over Last 12-Mos
Rating Score: 7.6 / 10
Percentile Rank: 82%
Avg. $ Target:
$169.44 (+19.7%)
* Over Last 12-Mos
Rating Score: 7.6 / 10
Percentile Rank: 82%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 12/20/2023 | Jefferies » Updated 2/8/2024 |
Kelly Shi | New Coverage | Buy (N/A) |
174.00 (172.00) |
120.89 (141.50) |
17.05% | Details |
| 10/20/2022 | Goldman Sachs » Updated 4/4/2023 |
Paul Choi | New Coverage | Buy (N/A) |
155.00 (175.00) |
112.19 (141.50) |
26.13% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
